Received Mar 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPVHIB | DTAP + IPV + HIB (PENTACEL) | SANOFI PASTEUR | 3 | UK149AB | IM |
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 3 | LG749 | IM |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 3 | LX2497 | IM |
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | N/A | Y014317 | PO / MO |
NO ADVERSE EVENT OCCURRED. DUE TO THE PATIENT'S HEALTH HISTORY, IT WAS MEDICALLY CONTRAINDICATED THAT THE PATIENT RECEIVE THE ROTAVIRUS VACCINE.
NONE. PATIENT HAD A COUGH THREE WEEKS PRIOR TO 3/12/2025.
ATRIAL SEPTAL DEFECT, CHRONIC KIDNEY DISEASE, FAILURE TO THRIVE, DISORDER OF KIDNEY & URETER, INUTERO EXPOSURE TO HUMIRA (UNABLE TO RECEIVE ROTAVIRUS VACCINE)
PEPCID
NONE
NONE